MENU
BIIB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Biogen (BIIB) Ownership - Who owns Biogen?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
31.34B
P/E Ratio
26.95
Total Cash
1.05B
Projected Growth
8.81
Total Debt
7.34B
Revenue
9.84B
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
7.22
Total Debt/Equity
6.50
Revenue/Share
67.55 USD as % of share price
Fundamentals
BIIB
Capitalization
31.3B
P/E Ratio
26.95
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
1.05B
Total Cash/Share
7.22
Total Debt
7.34B
Total Debt/Equity
6.50
Projected Growth (PEG Ratio)
8.81
Revenue/Share (as % of the share price)
67.55%
Revenue
9.84B
ROE
N/A
Book Value
14.8B
P/B Ratio
2.11
Cash Flow
N/A
Earnings
8.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
2.00
Current Revenue Per Employee
315231.20
Dividends Per Share - Security
N/A
EBITDA
2.04B
Float
N/A
Float - Current
N/A
Gross Income Margin
74.09
Revenue To Assets
4.52
Shares Held By Institutions
93.6B
Shares Outstanding - Current
145M
Total Liabilities
12B
Total Volume MTD
N/A
Value
-1
Gain YTD
-41.844
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com